The EU-CARDIOPROTECTION COST Action (CA16225) is a pan-European research network of leading experts in experimental and clinical cardioprotection, whose overall aim is to improve the translation of novel experimental cardioprotective therapies into the clinical setting for patient benefit.
Inaugural meeting – COST Action (CA16225 EU-CARDIOPROTECTION)March 11, 2018 | General
We had our inaugural meeting for our new COST Action (CA16225 EU-CARDIOPROTECTION 2017-2021) at the COST Headquarters in Brussels, October 2017. It was attended by over 50 management committee (MC) members from over 25 European countries with diverse and multi-disciplinary backgrounds and expertise in the field of cardioprotection. Together, we discussed the objectives of our […]